Takeda ready to dismiss assets for a total $10bn

Japan economic and financial daily Nihon KeizaiShimbun yesterday reported that Takeda Pharmaceutical is about to divest assets for $10bn in order to offset the debt–which has reached $48bn now–built up by acquiring Shire for $62bn. The newspaper also reports a statement by CFO Costa Saroukos, saying that no core assets will be dismissed.

(Source: Nihon Keizai Shimbun)